ARCHIVES

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

Hybridoma Cell Lines Available from NCI

September 3, 1982

TCGA Researchers Discover Stomach Cancer Falls Into Four Distinct Molecular Subtypes

August 29, 2014

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997